A Retrospective Analysis of Clinical and Epidemiological Aspects of Parvovirus B19 in Brazil: A Hidden and Neglected Virus Among Immunocompetent and Immunocompromised Individuals.

Arthur Daniel Rocha Alves, Luciane Almeida Amado
Author Information
  1. Arthur Daniel Rocha Alves: Laborat��rio de Desenvolvimento Tecnol��gico em Virologia, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil. ORCID
  2. Luciane Almeida Amado: Laborat��rio de Desenvolvimento Tecnol��gico em Virologia, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil.

Abstract

Parvovirus B19 (B19V) infection can affect individuals of all ages, both immunocompetent and immunocompromised. This infection is typically acute and self-limiting, most commonly resulting in rash diseases and acute febrile illness. However, its involvement in atypical manifestations such as chronic kidney disease and acute liver failure have also been reported. Diagnosis of B19V is rarely conducted in these populations, and available studies on its prevalence are limited, outdated, and do not accurately depict the current situation. This study describes and discusses retrospective investigations into the role of B19V in cases of rash diseases, acute febrile illness, anemia, occurring in the context of chronic kidney disease and HIV coinfection, and acute liver failure when no identifiable etiological agent was found, focusing on various populations in Brazil. This overview underscores the importance of recognizing the potential for severe B19V infection in all individuals, regardless of perceived immune status, as well as of considering the possibility of B19V concurrent infection, in both high-risk groups and healthy individuals to reduce the risk of serious complications and improve patient outcomes, by considering the inclusion of B19V in the routine of diagnosis and implementing management strategies. This study was limited by the absence of national surveillance data of B19V in Brazil and by the analyses that occurred retrospectively.

Keywords

References

  1. Leuk Res. 1996 Jan;20(1):81-3 [PMID: 8632681]
  2. Przegl Epidemiol. 2012;66(1):7-12 [PMID: 22708291]
  3. Future Microbiol. 2020 Mar;15:307-317 [PMID: 32286103]
  4. Viruses. 2023 May 08;15(5): [PMID: 37243210]
  5. Mem Inst Oswaldo Cruz. 2002 Oct;97(7):965-70 [PMID: 12471422]
  6. Eur J Pediatr. 2000 Jan-Feb;159(1-2):135-6 [PMID: 10653351]
  7. PLoS Negl Trop Dis. 2022 Oct 13;16(10):e0010727 [PMID: 36228027]
  8. Vox Sang. 2001 Nov;81(4):228-35 [PMID: 11903998]
  9. Rev Soc Bras Med Trop. 2001 May-Jun;34(3):239-42 [PMID: 11460208]
  10. J Clin Microbiol. 1986 Oct;24(4):522-6 [PMID: 3021807]
  11. Rev Inst Med Trop Sao Paulo. 2000 Nov-Dec;42(6):305-11 [PMID: 11136516]
  12. Euro Surveill. 2024 Jul;29(29): [PMID: 39027940]
  13. Viruses. 2021 Mar 24;13(4): [PMID: 33805034]
  14. J Med Virol. 2016 Apr;88(4):588-95 [PMID: 26369294]
  15. PLoS Negl Trop Dis. 2024 Sep 23;18(9):e0012536 [PMID: 39312587]
  16. Braz J Infect Dis. 2020 May - Jun;24(3):250-255 [PMID: 32422120]
  17. Transfus Med. 2014 Apr;24(2):130-2 [PMID: 24684574]
  18. Clin Microbiol Infect. 2013 Jan;19(1):E31-E43 [PMID: 23167493]
  19. Int J Infect Dis. 2020 Nov;100:350-356 [PMID: 32927082]
  20. Rev Soc Bras Med Trop. 2019 Sep 05;52:e20190304 [PMID: 31508787]
  21. Clin Diagn Lab Immunol. 1996 Mar;3(2):147-50 [PMID: 8991627]
  22. J Med Virol. 2001 Oct;65(2):395-401 [PMID: 11536250]
  23. Lancet. 1988 Nov 19;2(8621):1159-62 [PMID: 2903376]
  24. Viruses. 2024 Jan 25;16(2): [PMID: 38399956]
  25. J Infect Dis. 1985 Aug;152(2):257-65 [PMID: 2993431]
  26. J Clin Virol. 2024 Dec;175:105739 [PMID: 39427370]
  27. Mem Inst Oswaldo Cruz. 2011 Jun;106(4):502-4 [PMID: 21739041]
  28. Commun Dis Rep CDR Rev. 1994 Aug 19;4(9):R104-7 [PMID: 7522807]
  29. AIDS. 1992 Jul;6(7):679-84 [PMID: 1503687]
  30. Virol J. 2025 Jan 20;22(1):15 [PMID: 39833889]
  31. Epidemiol Infect. 2002 Feb;128(1):59-62 [PMID: 11895091]
  32. Euro Surveill. 2024 Jun;29(25): [PMID: 38904112]
  33. J Clin Microbiol. 2006 Feb;44(2):604-6 [PMID: 16455922]
  34. Blood Transfus. 2021 Mar;19(2):93-101 [PMID: 33000756]
  35. J Clin Microbiol. 2009 Nov;47(11):3735-8 [PMID: 19741071]
  36. Mem Inst Oswaldo Cruz. 2012 May;107(3):356-61 [PMID: 22510831]
  37. J Clin Pathol. 1991 Oct;44(10):831-4 [PMID: 1660053]
  38. J Virol. 2003 Mar;77(5):2915-21 [PMID: 12584315]
  39. J Virol. 1986 Jun;58(3):921-36 [PMID: 3701931]
  40. Curr Opin Virol. 2017 Dec;27:8-14 [PMID: 29096233]
  41. J Pediatr. 1990 Mar;116(3):355-9 [PMID: 1689774]
  42. Rev Soc Bras Med Trop. 2006 Sep-Oct;39(5):467-72 [PMID: 17160325]
  43. J Appl Microbiol. 2018 Apr;124(4):1008-1016 [PMID: 29464825]
  44. J Med Microbiol. 1988 Feb;25(2):151-3 [PMID: 3339634]
  45. Eur J Pediatr. 1992 Nov;151(11):815-7 [PMID: 1468455]
  46. J Clin Microbiol. 2014 Mar;52(3):947-56 [PMID: 24403307]
  47. J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):739-46 [PMID: 12438480]
  48. Virology. 2008 Nov 25;381(2):168-77 [PMID: 18838151]
  49. J Clin Virol. 2017 Oct;95:10-11 [PMID: 28822317]
  50. Lancet. 1996 Mar 30;347(9005):868-9 [PMID: 8622394]
  51. Transplantation. 1993 Feb;55(2):427-30 [PMID: 8434395]
  52. Rev Bras Hematol Hemoter. 2016 Jul-Sep;38(3):271-3 [PMID: 27521868]
  53. J Clin Virol. 2002 Aug;25(2):223-30 [PMID: 12367658]
  54. PLoS One. 2020 Mar 5;15(3):e0229993 [PMID: 32134963]
  55. Viruses. 2024 Mar 20;16(3): [PMID: 38543845]
  56. Rev Assoc Med Bras (1992). 2017 Mar;63(3):224-228 [PMID: 28489127]
  57. Infect Genet Evol. 2023 Sep;113:105487 [PMID: 37544570]
  58. Arch Virol. 1999;144(9):1713-24 [PMID: 10542021]
  59. Lancet. 1996 Jun 1;347(9014):1563-4 [PMID: 8684141]
  60. J Infect Dis. 1995 Nov;172(5):1198-205 [PMID: 7594654]
  61. Br J Haematol. 1989 Feb;71(2):300 [PMID: 2538139]
  62. Clin Microbiol Rev. 2002 Jul;15(3):485-505 [PMID: 12097253]
  63. J Virol. 2004 Jul;78(14):7775-83 [PMID: 15220451]
  64. Rev Saude Publica. 2008 Jun;42(3):443-9 [PMID: 18425294]
  65. Epidemiol Mikrobiol Imunol. 1995 Dec;44(4):171-4 [PMID: 8556246]
  66. Lancet. 1994 May 21;343(8908):1255-8 [PMID: 7910276]
  67. J Med Virol. 2012 Oct;84(10):1652-65 [PMID: 22930515]
  68. J Clin Microbiol. 2011 Apr;49(4):1578-80 [PMID: 21307212]
  69. Viruses. 2024 Aug 24;16(9): [PMID: 39339829]
  70. Lancet. 2017 Mar 25;389(10075):1238-1252 [PMID: 27887750]
  71. Rev Soc Bras Med Trop. 2008 Jul-Aug;41(4):338-44 [PMID: 18853004]
  72. Transfusion. 2007 Oct;47(10):1775-82 [PMID: 17714425]
  73. Ann Intern Med. 1990 Dec 15;113(12):926-33 [PMID: 2173460]
  74. Ann Med. 1992 Apr;24(2):137 [PMID: 1610541]
  75. Clin Infect Dis. 2019 Feb 15;68(5):810-817 [PMID: 30304533]
  76. Proc Natl Acad Sci U S A. 2006 May 9;103(19):7450-3 [PMID: 16651522]
  77. Am J Pediatr Hematol Oncol. 1989 Winter;11(4):441-4 [PMID: 2559623]
  78. J Clin Virol. 2009 Jan;44(1):33-8 [PMID: 19058999]
  79. Clin Chim Acta. 2014 Apr 20;431:52-7 [PMID: 24513539]
  80. Rev Soc Bras Med Trop. 2010 May-Jun;43(3):234-9 [PMID: 20563487]
  81. J Clin Virol. 2016 Nov;84:19-23 [PMID: 27664778]
  82. J Pers Med. 2024 Jan 26;14(2): [PMID: 38392573]
  83. Virus Res. 2014 Sep 22;190:8-16 [PMID: 24998884]
  84. Rev Inst Med Trop Sao Paulo. 1990 Jan-Feb;32(1):41-5 [PMID: 2175446]
  85. Clin Microbiol Rev. 2017 Jan;30(1):43-113 [PMID: 27806994]
  86. J Med Virol. 2008 Jul;80(7):1243-51 [PMID: 18461615]
  87. Indian J Med Res. 2002 Apr;115:139-43 [PMID: 12239835]
  88. N Engl J Med. 1987 Jul 30;317(5):287-94 [PMID: 3037373]
  89. Reprod Toxicol. 2006 May;21(4):350-82 [PMID: 16564672]
  90. Braz J Infect Dis. 2017 Jan - Feb;21(1):102-106 [PMID: 27914222]
  91. Rev Inst Med Trop Sao Paulo. 1996 Sep-Oct;38(5):323-7 [PMID: 9293073]
  92. J Pediatr. 1985 Jul;107(1):38-40 [PMID: 2989471]
  93. J Med Virol. 2019 Jul;91(7):1224-1231 [PMID: 30851123]
  94. Am J Hematol. 1993 Nov;44(3):207-9 [PMID: 8213773]
  95. Epidemiol Infect. 2001 Dec;127(3):509-16 [PMID: 11811885]
  96. J Med Virol. 1990 Dec;32(4):203-8 [PMID: 1964474]
  97. Clin Infect Dis. 2008 Dec 15;47(12):1519-25 [PMID: 18991512]
  98. Rev Soc Bras Med Trop. 2005 Sep-Oct;38(5):396-8 [PMID: 16172754]
  99. Microbiol Spectr. 2016 Jun;4(3): [PMID: 27337440]
  100. MMWR Morb Mortal Wkly Rep. 2024 Nov 28;73(47):1076-1081 [PMID: 39602409]
  101. Mem Inst Oswaldo Cruz. 2014 Apr;109(2):168-73 [PMID: 24714965]
  102. Pediatr Infect Dis J. 2009 Jul;28(7):649-50 [PMID: 19483661]
  103. Ann Hematol. 1992 Jun;64 Suppl:A121-4 [PMID: 1637889]
  104. Mem Inst Oswaldo Cruz. 2011 May;106(3):371-3 [PMID: 21655829]
  105. Orv Hetil. 2012 Dec 9;153(49):1948-57 [PMID: 23204301]
  106. Arch Intern Med. 1989 May;149(5):1153-6 [PMID: 2541666]
  107. Sci Rep. 2024 Apr 26;14(1):9630 [PMID: 38671058]
  108. Clin J Am Soc Nephrol. 2007 Jul;2 Suppl 1:S47-56 [PMID: 17699510]
  109. Enferm Infecc Microbiol Clin. 2000 May;18(5):243-4 [PMID: 10974772]
  110. Intervirology. 2016;59(3):179-185 [PMID: 28142135]
  111. J Clin Virol. 2008 Sep;43(1):60-5 [PMID: 18502682]
  112. Can J Microbiol. 2012 Feb;58(2):200-5 [PMID: 22280886]
  113. Evolution. 1985 Jul;39(4):783-791 [PMID: 28561359]
  114. Nephrol Dial Transplant. 1998 Mar;13(3):779-80 [PMID: 9550669]
  115. J Clin Microbiol. 2004 Jul;42(7):3191-5 [PMID: 15243081]
  116. Mol Biol Evol. 1993 May;10(3):512-26 [PMID: 8336541]
  117. Transplant Direct. 2017 Oct 02;3(11):e217 [PMID: 29184906]
  118. Arthritis Rheum. 1996 May;39(5):880-1 [PMID: 8639187]
  119. Hepat Res Treat. 2013;2013:472027 [PMID: 24232179]
  120. PLoS One. 2022 Jul 29;17(7):e0271758 [PMID: 35905118]
  121. J Hepatol. 2003 Mar;38(3):375-6 [PMID: 12586308]
  122. Pediatr Ann. 2020 Mar 1;49(3):e116-e123 [PMID: 32155277]
  123. N Engl J Med. 2004 Feb 5;350(6):586-97 [PMID: 14762186]
  124. Front Microbiol. 2024 Jul 18;15:1417434 [PMID: 39091305]
  125. Rev Soc Bras Med Trop. 1997 Jan-Feb;30(1):15-20 [PMID: 8993105]
  126. Future Microbiol. 2021 Jan;16(1):37-50 [PMID: 33438475]
  127. Pediatr Infect Dis J. 2017 Dec;36(12):e355-e358 [PMID: 28787384]
  128. Hepatology. 1995 Dec;22(6):1661-5 [PMID: 7489971]
  129. Int J Med Sci. 2007 Apr 05;4(2):105-9 [PMID: 17479159]
  130. Virol J. 2011 Feb 28;8:87 [PMID: 21352606]
  131. Mem Inst Oswaldo Cruz. 2005 Dec;100(8):847-52 [PMID: 16444415]
  132. Braz J Infect Dis. 1999 Feb;3(1):6-14 [PMID: 11098187]
  133. Arch Virol. 2009;154(10):1685-7 [PMID: 19701602]
  134. Rev Soc Bras Med Trop. 2004 Nov-Dec;37(6):476-9 [PMID: 15765597]
  135. Viruses. 2022 Apr 18;14(4): [PMID: 35458573]
  136. Mem Inst Oswaldo Cruz. 1993 Jul-Sep;88(3):497-9 [PMID: 8107612]
  137. PLoS Negl Trop Dis. 2023 Nov 2;17(11):e0011701 [PMID: 37917659]
  138. Transplantation. 1993 Oct;56(4):835-8 [PMID: 8212203]
  139. Int J Clin Oncol. 2016 Oct;21(5):989-995 [PMID: 27225490]
  140. J Infect Dis. 2003 May 15;187(10):1581-6 [PMID: 12721938]
  141. Transfusion. 2013 Oct;53(10 Pt 2):2556-66 [PMID: 23145866]
  142. Br J Dermatol. 1999 Jul;141(1):160-1 [PMID: 10417538]
  143. Microorganisms. 2024 Oct 24;12(11): [PMID: 39597523]

Grants

  1. FAPERJ-JCNE (number: e-26/201.406/2021), FAPERJ-JCM (number: e-26/210.058/2024), FAPERJ-PDR10 (number: e-26/205.975/2022)./Funda����o Carlos Chagas Filho de Amparo �� Pesquisa do Estado do Rio de Janeiro
  2. 001/Coordena����o de Aperfeicoamento de Pessoal de N��vel Superior
  3. Instituto Oswaldo Cruz/Funda����o Oswaldo Cruz

MeSH Term

Humans
Brazil
Parvovirus B19, Human
Immunocompromised Host
Retrospective Studies
Parvoviridae Infections
Female
Prevalence
Male
Adult
Immunocompetence
Neglected Diseases
Coinfection
Young Adult
Middle Aged
HIV Infections

Word Cloud

Created with Highcharts 10.0.0B19VinfectionacuteParvovirusB19individualsrashdiseasesfebrileillnesschronickidneydiseaseliverfailurepopulationsprevalencelimitedstudyBrazilconsideringdiagnosiscanaffectagesimmunocompetentimmunocompromisedtypicallyself-limitingcommonlyresultingHoweverinvolvementatypicalmanifestationsalsoreportedDiagnosisrarelyconductedavailablestudiesoutdatedaccuratelydepictcurrentsituationdescribesdiscussesretrospectiveinvestigationsrolecasesanemiaoccurringcontextHIVcoinfectionidentifiableetiologicalagentfoundfocusingvariousoverviewunderscoresimportancerecognizingpotentialsevereregardlessperceivedimmunestatuswellpossibilityconcurrenthigh-riskgroupshealthyreduceriskseriouscomplicationsimprovepatientoutcomesinclusionroutineimplementingmanagementstrategiesabsencenationalsurveillancedataanalysesoccurredretrospectivelyRetrospectiveAnalysisClinicalEpidemiologicalAspectsBrazil:HiddenNeglectedVirusAmongImmunocompetentImmunocompromisedIndividuals

Similar Articles

Cited By

No available data.